The Drug Dealer Simulator series, whose publisher has launched a copyright infringement investigation against Schedule 1, is seeing a wave of negative reviews popping up on Steam. This backlash from Schedule 1 fans in the wake of its recent launch is causing a big drop in lifetime user rating percentages for both Drug Dealer Simulator games.
Developed by Byterunners and published by Movie Games S.A., Drug Dealer Simulator and Drug Dealer Simulator 2 were originally released in 2020 and 2024, respectively. Though the original game is still showing solid all-time review scores, both games combined have not matched the instant popularity of Schedule 1, a co-op crime simulator that launched on March 24 and has been consistently seeing at least 318,000 peak daily concurrent users throughout the last week.
Here's how to get your business moving in Schedule 1 and start turning a profit.
However, in the past few days, both Drug Dealer Simulator games have seen a massive number of mostly negative reviews popping up on their Steam pages. This phenomenon is almost certainly a reaction to the copyright infringement investigation against Schedule 1 by a legal consultant hired by Movie Games S.A.'s management board, which was...
